In addition toaddressing themechanisms ofcell division, this "unprecedented" moleculecould help"starve" tumoursby preventing them fromcreating their ownvascular network
NEWS
February 11 th, 2015
. ET-D5 isthe name of theanti-cancermoleculedeveloped bythe start-upGrenobleJewel-Therapeutics. Their goalis toinitiateclinicaltrials in humansby 2016. So far, in fact, the molecule that attackstumourcell divisionhas only been testedin mice"with verygood results,"according to theScientific Director ofEcrinsTherapeutics.
The youngest Microsoft graduate made headline news in British newspapers. Ayan Qureshi (5) poses next to his computer